SonoScape Medical Corp - Asset Resilience Ratio

Latest as of March 2026: 0.21%

SonoScape Medical Corp (300633) has an Asset Resilience Ratio of 0.21% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check SonoScape Medical Corp (300633) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥9.11 Million
≈ $1.33 Million USD Cash + Short-term Investments

Total Assets

CN¥4.30 Billion
≈ $629.09 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how SonoScape Medical Corp's Asset Resilience Ratio has changed over time. See how leveraged is SonoScape Medical Corp's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down SonoScape Medical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of SonoScape Medical Corp.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥9.11 Million 0.21%
Total Liquid Assets CN¥9.11 Million 0.21%

Asset Resilience Insights

  • Limited Liquidity: SonoScape Medical Corp maintains only 0.21% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

SonoScape Medical Corp Industry Peers by Asset Resilience Ratio

Compare SonoScape Medical Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
APT Medical Inc
SHG:688617
Medical Devices 8.63%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Neuronetics Inc
NASDAQ:STIM
Medical Devices 0.20%
Epitomee Medical Ltd
TA:EPIT
Medical Devices 0.24%
Respiri Ltd
AU:RSH
Medical Devices 0.46%

Annual Asset Resilience Ratio for SonoScape Medical Corp (2018–2025)

The table below shows the annual Asset Resilience Ratio data for SonoScape Medical Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 5.38% CN¥237.16 Million
≈ $34.70 Million
CN¥4.41 Billion
≈ $644.78 Million
-4.78pp
2024-12-31 10.17% CN¥438.46 Million
≈ $64.16 Million
CN¥4.31 Billion
≈ $631.13 Million
+8.80pp
2023-12-31 1.36% CN¥51.39 Million
≈ $7.52 Million
CN¥3.77 Billion
≈ $551.88 Million
-10.47pp
2022-12-31 11.83% CN¥419.45 Million
≈ $61.38 Million
CN¥3.54 Billion
≈ $518.63 Million
+7.03pp
2021-12-31 4.81% CN¥145.24 Million
≈ $21.25 Million
CN¥3.02 Billion
≈ $441.97 Million
-10.97pp
2020-12-31 15.78% CN¥355.32 Million
≈ $51.99 Million
CN¥2.25 Billion
≈ $329.53 Million
-12.79pp
2019-12-31 28.56% CN¥689.65 Million
≈ $100.92 Million
CN¥2.41 Billion
≈ $353.30 Million
+29.22pp
2018-12-31 -0.65% CN¥-11.96 Million
≈ $-1.75 Million
CN¥1.84 Billion
≈ $268.61 Million
--
pp = percentage points

About SonoScape Medical Corp

SHE:300633 China Medical Devices
Market Cap
$1.14 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#8375 Global
#2016 in China
Share Price
CN¥17.97
Change (1 day)
-4.01%
52-Week Range
CN¥17.97 - CN¥36.61
All Time High
CN¥60.46
About

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more